Cosylab Launches PlanOne™ Treatment Planning System for Particle Therapy
Cosylab today announced the commercial launch of PlanOne™, a treatment planning system for particle therapy, bringing physics-accurate, radiobiologically informed planning and a unified clinical workflow into a single environment. PlanOne™ is FDA 510(k) cleared.
April 22, 2026
Complex Sales: Like a Game of Chess and Poker, Not a Sprint
NV Centre Quantum Sensing Ready for Commercial Use
Cosylab, a provider of control systems engineering solutions for science and deep-tech industry, held a webinar "From Lab to Fab: Quantum Sensing and NV Control" that investigated the challenges of transitioning quantum sensing from laboratory prototypes to real-world systems, and how to meet them.
Events
News
Quantum
Webinars
From Lab to Fab: Quantum Sensing & NV Control
News
Slovenia’s Success in FAIR Project
Fusion
News
Cosylab’s CEO Speaks at the European Fusion Industry Forum
Cosylab CEO, Dr Mark Pleško, takes part in the prestigious European Fusion Industry Forum in Berlin from July 3rd to 4th, 2024, organised by the European Commission!
News
Quantum
Cosylab Launches starQ: A New Embedded Control Toolkit for Quantum Sensors
StarQ debuts at the Q2B Paris Conference as a flexible, IP-friendly device for boosting experiment accuracy and accelerating MVP development in quantum NV sensing.
News
Cosylab joins ASTRO as an official corporate Member!
We are honoured to announce Cosylab is now an official Corporate Member of the American Society for Radiation Oncology (ASTRO).
Events
Quantum
Meet Cosylab at Q2B Paris 2025
Whether you're developing a quantum sensor, synchronising a QKD system, or scaling a platform from lab to fab, Cosylab is here to support you with services and solutions that cover the entire control stack, from idea to proof of concept to certification.
Do you have a question or a project?
Get in touch with our experts to see how we can help.
